Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,179 USD | -2,08% |
|
+6,55% | +27,86% |
20/05 | Elite Pharmaceuticals ontvangt goedkeuring van de FDA voor generiek Methotrexaat | CI |
15/02 | Transcript : Elite Pharmaceuticals, Inc., Q3 2024 Earnings Call, Feb 15, 2024 |
Vakgebied
Aantal werknemers: 53
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Abbreviated New Drug Applications
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 32 | 100,0 % | 34 | 100,0 % | +5,87% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Carter Ward
DFI | Director of Finance/CFO | 59 | 01-07-09 |
Christopher Dick
PSD | President | 69 | 01-11-02 |
Douglas Plassche
COO | Chief Operating Officer | 61 | 12-08-13 |
Dianne Will
IRC | Investor Relations Contact | - | 01-01-03 |
Kirko Kirkov
PRN | Corporate Officer/Principal | 56 | 06-09-22 |
George Smith
LAW | General Counsel | - | 20-10-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jeffrey Whitnell
BRD | Director/Board Member | 68 | 23-10-09 |
Barry Dash
BRD | Director/Board Member | 93 | 01-04-05 |
Davis Caskey
BRD | Director/Board Member | 76 | 28-04-16 |
Nasrat Hakim
CEO | Chief Executive Officer | 63 | 01-08-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 017 881 199 | 791 526 006 ( 77,76 %) | 100 000 ( 0,009824 %) | 77,76 % |
Bedrijfsgegevens
![Adres Elite Pharmaceuticals, Inc.(ELTP)](https://cdn.zonebourse.com/static/address/120786915.png)
Sector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,86% | 191 mln. | |
+20,39% | 43,67 mld. | |
+26,21% | 22,79 mld. | |
+21,21% | 15,45 mld. | |
+18,82% | 14,29 mld. | |
+53,37% | 12,83 mld. | |
-0,05% | 6,79 mld. | |
-11,88% | 6,52 mld. | |
+12,62% | 5,59 mld. | |
-8,87% | 5,73 mld. |
- Beurs
- Aandelen
- Koers ELTP
- Onderneming Elite Pharmaceuticals, Inc.